Latest Kaiser Health News Stories
En otra consecuencia de la crisis de la cadena de suministro global, hospitales que gestionan los picos de casos de covid durante las Fiestas y a todos sus otros pacientes se están quedando sin suministros básicos para atenderlos
As hospitals juggle holiday covid surges and all their other patients, the global supply chain crisis has left them short of critical supplies.
La variante omicron, conocida oficialmente como B.1.1.529, apareció en noviembre en varios países del sur de África. Las alarmas saltaron en todo el mundo cuando los funcionarios de salud pública de Sudáfrica vieron que empezaba a superar a delta, la cepa dominante hasta ahora.
This new variant has set off alarm bells in the public health community, but much remains to be learned about it.
Covid is back with a vengeance, with some people clamoring for booster shots while others harden their resistance to getting vaccinated at all. Meanwhile, the Food and Drug Administration is pushing hard on drugmaker Pfizer’s request to upgrade the emergency authorization for its vaccine and give it final approval. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.
Scientists are trying to piece together why the delta variant so readily infects unvaccinated Americans, spewing 1,000 times more virus particles.
Delta ha mantenido algunas de las mutaciones más exitosas encontradas en variantes anteriores, pero también contiene nuevos cambios genéticos que le permiten propagarse dos veces más rápido.
In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely.
Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn’t come through with a licensed covid vaccine. It hopes it can still help to fight the global covid scourge, but will it deliver?
The data is reassuring to people who got this shot.
If international scientific sleuths are hoping to see a lab log or find a whistleblower, that sort of information won’t be revealed. In China today, it is dangerous to say what you know if it challenges the official government narrative.
The World Health Organization this week updated its guidance on children and covid vaccinations — but in a different way than alleged in a viral social media post.
About three dozen elite health systems are involved in for-profit hospital projects overseas. Though the systems are exempt from U.S. taxes for providing “community benefit,” there’s limited evidence that such business ventures benefit American patients.
Where the coronavirus originated remains a mystery and the Chinese are bucking demands to let investigators see more.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Lawmakers are working on fleshing out the concept of a “public option,” a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
The newly conservative Supreme Court will hear a case that could overturn the nationwide right to abortion and cause political upheaval. Meanwhile, the Centers for Disease Control and Prevention’s abrupt announcement that vaccinated people can take off their masks in most places has caused upheaval of its own. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
La idea de que el virus que causa covid escapó de un laboratorio chino, una teoría que en su momento se consideró conspirativa, está cobrando fuerza. Al mismo tiempo, peligra la reputación de renombrados científicos, al igual que su seguridad personal.
Leading virologists, including Dr. Anthony Fauci, are demanding a deeper probe into China’s Wuhan Institute of Virology as they try to identify the source of the deadly coronavirus.
All agree that covid vaccines are urgently needed to stop the pandemic, but simply waiving patents fails to provide technological know-how and address supply chain challenges.